Breast imaging referrers ordering more MRI scans following legislation

Referring physicians who have the option to send women for breast MRI are unclear on the exam’s clinical usefulness. That goes for specialists as well as primary-care providers. However, at an academic hospital system in Boston, all referring providers have been ordering more breast MRI since Massachusetts began requiring mammographers to inform patients in writing of their breast density.

So found breast radiologists at Beth Israel Deaconess Medical Center when they surveyed their referral base. The Harvard researchers had their findings published online in The Breast.  

Senior author Vandana Dialani, MD, and colleagues received completed surveys from 134 ordering providers of 525 on their distribution list (a 26 percent response rate).

Reviewing the responses, they found 42 percent (n = 57) order breast MRI in practice, most commonly for high-risk screening (84 percent).

At the same time, 79 percent of MRI-comfortable referrers (n = 45) order fewer than 10 exams per year.

Referrers who don’t order breast MRI collectively identified lack of familiarity as the most consistent reason (32 of 77, or 42 percent).

Primary-care docs order breast MRI less frequently than specialists, yet both have mixed perceptions of the clinical utility of breast MRI, the authors reported.

Despite the widespread reticence, some 30 percent of survey respondents said they’ve ordered more breast MRI since the January 2015 enactment of legislation mandating density notification in the Bay State.

Additionally, 29 percent indicated they would order breast MRI more often to screen women with dense breasts if there was a low-cost option.

“Our study suggests a growing clinical interest in breast MRI for screening; however, there is a need for provider education on the clinical utility of breast MRI,” the authors wrote. “Increasing the radiologist’s role in targeted educational interventions may help improve awareness and lead to more appropriate utilization of resources.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup